Cardiovascular morbidity in psoriatic arthritis

被引:218
作者
Gladman, D. D. [1 ]
Ang, M. [1 ]
Su, L. [2 ]
Tom, B. D. M. [2 ]
Schentag, C. T. [1 ]
Farewell, V. T. [2 ]
机构
[1] Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, Psoriat Arthritis Program, Toronto, ON M5T 2S8, Canada
[2] MRC, Inst Publ Hlth, Biostat Unit, Cambridge, England
基金
英国医学研究理事会;
关键词
CONGESTIVE-HEART-FAILURE; RHEUMATOID-ARTHRITIS; RISK-FACTORS; DISEASE; ATHEROSCLEROSIS; MORTALITY; PREVALENCE; DEATH;
D O I
10.1136/ard.2008.094839
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Increasing evidence for cardiovascular mortality among patients with psoriasis and psoriatic arthritis (PsA) has accumulated, together with evidence for increased prevalence of risk factors for cardiovascular disease (CVD). Objectives: To describe cardiovascular morbidity in PsA, determine its prevalence and identify risk factors for its development. Methods: At the University of Toronto, patients were followed up prospectively according to a standard protocol, including disease-related features and comorbidities. Patients with CVD, including myocardial infarction (MI), angina, hypertension and cerebrovascular accident (CVA), were identified. The prevalence of CVD morbidities in these patients was compared with data from the Canadian Community Health Survey through standardised prevalence ratios (SPRs). Cox relative risk regression analysis was used to analyse risk factors. Results: At the time of analysis, 648 patients were registered in the database. After clinic entry, 122 developed hypertension, 38 had an MI and 5, 21 and 11 had CVA, angina and congestive heart failure (CHF), respectively. 155 patients had at least one of these conditions. The SPRs for MI (2.57; 95% CI 1.73 to 3.80), angina (1.97; 95% CI 1.24 to 3.12) and hypertension (1.90; 95% CI 1.59 to 2.27) were statistically significant, whereas the SPRs for CHF (1.19; 95% CI 0.50 to 2.86) and CVA (0.91; 95% CI 0.34 to 2.43) were not. Factors associated with CVD included diabetes, hyperlipidaemia and high Psoriasis Area and Severity Index scores. Conclusion: Patients with PsA are at increased risk of cardiovascular morbidities compared with the general population. In addition to known risk factors for CVD, severe psoriasis is an important predictor in patients with PsA.
引用
收藏
页码:1131 / 1135
页数:5
相关论文
共 41 条
[11]  
2-N
[12]  
GLADMAN DD, 1987, Q J MED, V62, P127
[13]   Rheumatoid arthritis: A disease associated with accelerated atherogenesis [J].
Gonzalez-Gay, MA ;
Gonzalez-Juanatey, C ;
Martin, J .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2005, 35 (01) :8-17
[14]   High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors [J].
Gonzalez-Juanatey, Carlos ;
Llorca, Javier ;
Amigo-Diaz, Encarnacion ;
Dierssen, Trinidad ;
Martin, Javier ;
Gonzalez-Gay, Miguel A. .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (06) :1074-1080
[15]   Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors [J].
Gonzalez-Juanatey, Carlos ;
Llorca, Javier ;
Miranda-Filloy, Jose A. ;
Amigo-Diaz, Encarnacion ;
Testa, Ana ;
Garcia-Porrua, Carlos ;
Martin, Javier ;
Gonzalez-Gay, Miguel A. .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (02) :287-293
[16]  
Han CL, 2006, J RHEUMATOL, V33, P2167
[17]  
Jonsson SW, 2001, J RHEUMATOL, V28, P2597
[18]   Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis [J].
Kimhi, Oded ;
Caspi, Dan ;
Bornstein, Natan M. ;
Maharshak, Nitsan ;
Gur, Alexander ;
Arbel, Yaron ;
Comaneshter, Doron ;
Paran, Daphna ;
Wigler, Irena ;
Levartovsky, David ;
Berliner, Shlomo ;
Elkayam, Ori .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2007, 36 (04) :203-209
[19]   Tackling ischaemic heart disease in rheumatoid arthritis [J].
Kitas, GD ;
Erb, N .
RHEUMATOLOGY, 2003, 42 (05) :607-613
[20]   Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients [J].
Kural, BV ;
Örem, A ;
Çimsit, G ;
Uydu, HA ;
Yandi, YE ;
Alver, A .
CLINICA CHIMICA ACTA, 2003, 332 (1-2) :23-30